Multicenter DSC–MRI-based radiomics predict IDH mutation in gliomas

27Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

To address the current lack of dynamic susceptibility contrast magnetic resonance imaging (DSC–MRI)-based radiomics to predict isocitrate dehydrogenase (IDH) mutations in gliomas, we present a multicenter study that featured an independent exploratory set for radiomics model development and external validation using two independent cohorts. The maximum performance of the IDH mutation status prediction on the validation set had an accuracy of 0.544 (Cohen’s kappa: 0.145, F1-score: 0.415, area under the curve-AUC: 0.639, sensitivity: 0.733, specificity: 0.491), which significantly improved to an accuracy of 0.706 (Cohen’s kappa: 0.282, F1-score: 0.474, AUC: 0.667, sensitivity: 0.6, specificity: 0.736) when dynamic-based standardization of the images was per-formed prior to the radiomics. Model explainability using local interpretable model-agnostic explanations (LIME) and Shapley additive explanations (SHAP) revealed potential intuitive correlations between the IDH–wildtype increased heterogeneity and the texture complexity. These results strengthened our hypothesis that DSC–MRI radiogenomics in gliomas hold the potential to provide increased predictive performance from models that generalize well and provide understandable patterns between IDH mutation status and the extracted features toward enabling the clinical trans-lation of radiogenomics in neuro-oncology.

Cite

CITATION STYLE

APA

Manikis, G. C., Ioannidis, G. S., Siakallis, L., Nikiforaki, K., Iv, M., Vozlic, D., … Marias, K. (2021). Multicenter DSC–MRI-based radiomics predict IDH mutation in gliomas. Cancers, 13(16). https://doi.org/10.3390/cancers13163965

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free